GFL Environmental Inc. Subordinate voting shares no par value vs Natera Inc. Common Stock — how do they compare? GFL Environmental Inc. Subordinate voting shares no par value trades at $42.95 (market cap $18.64B), while Natera Inc. Common Stock trades at $393.27 (market cap $57.03B). The key difference: Natera Inc. Common Stock is far larger — about 3.1× GFL Environmental Inc. Subordinate voting shares no par value's market cap, and GFL Environmental Inc. Subordinate voting shares no par value pays a 0.16% dividend while Natera Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold GFL Environmental Inc. Subordinate voting shares no par value for 6 Days and Natera Inc. Common Stock for 0 Days on average.
| GFL | NTRA | |
|---|---|---|
Market Cap | $18.64B | $57.03B |
Volume | 2,514,524 | 1,131,157 |
Sector | Industrials | Health |
52-Week High | $46.51 | $425.64 |
52-Week Low | $33.54 | $179.42 |
Typical Hold Time | 6 Days | 0 Days |
Enterprise Value | $25.61B | $56.18B |
Dividend Yield | 0.16% | — |
Signals from Pluang's Aura AI — not financial advice
GFL trades at $42.75, up 0.87% today, with a bullish technical signal from moving averages. Recent Q2 2026 earnings missed estimates, but the company raised full-year 2026 guidance. Revenue is projected to grow to $7.0B in 2026, though net income is expected to turn negative. The company recently acquired SECURE Waste Infrastructure and announced a quarterly dividend, signaling financial activity.
Outlook is mixed: strong analyst buy consensus (77.8%) and positive news flow support upside, but negative profit margins and high valuation ratios pose risks. The stock's performance hinges on execution of growth initiatives and margin improvement in a competitive industrial sector.
NTRA trades at $395.66, down 0.53% today but remains near recent highs. The stock shows mixed technical signals with neutral momentum indicators. Fundamentally, the company demonstrates strong revenue growth ($2.31B in 2025, projected $2.7B in 2026) but continues to operate at a net loss (-$208M in 2025). Recent positive developments include FDA Breakthrough Device designation for its multi-cancer detection assay and regulatory approval in Japan for Signatera.
NTRA presents a growth story with significant analyst support (89% buy ratings) but carries execution risks. The stock trades at premium valuations (P/S 20.48) while still unprofitable. Key catalysts include clinical trial progress and international expansion, though investors face risks from ongoing losses and competitive pressures in precision medicine.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
GFL Environmental provides environmental services across Canada and the United States. Its operations include solid waste management and other waste and environmental solutions.
Read more on GFL →Natera, Inc. develops and provides cell-free DNA-based genetic testing across women's health, oncology, organ health, and rare disease, with flagship products including Panorama for noninvasive prenatal screening and Signatera for cancer recurrence monitoring.
Read more on NTRA →